UVA Today

UVA team unveils simpler, faster way to make vaccines

UVA Health researchers are advancing a technology that may allow new vaccines to be designed, tested and distributed in weeks ...
The Manila Times

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...

Merck & Co., Inc. (MRK) and CEPI launch effort to make Ebola vaccine cheaper and easier to distribute

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

Merck partners with global health coalition to develop affordable Ebola vaccine

Jan 21 (Reuters) - Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a ...
National Academies of Sciences%2c Engineering%2c and Medicine

The Search for a COVID-19 Vaccine — ‘There’s No One Winner’

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...